Interactions of the tricyclic antidepressant drug amitriptyline with L-DOPA in the striatum and substantia nigra of unilaterally 6-OHDA-lesioned rats. Relevance to motor dysfunction in Parkinson's disease-Reference-Cited by-同舟云学术

Interactions of the tricyclic antidepressant drug amitriptyline with L-DOPA in the striatum and substantia nigra of unilaterally 6-OHDA-lesioned rats. Relevance to motor dysfunction in Parkinson's disease

Published:2018-12 Issue: Volume:121 Page:125-139
ISSN:0197-0186
Container-title:Neurochemistry International
language:en
Short-container-title:Neurochemistry International

Author:

Kamińska Kinga,Lenda Tomasz,Konieczny Jolanta,Wardas Jadwiga^ORCID,Lorenc-Koci Elżbieta

Funder

European Regional Development Fund of (ERDF)

Institute of Pharmacology

Polish Academy of Sciences

Publisher

Elsevier BV

Subject

Cell Biology,Cellular and Molecular Neuroscience

Reference103 articles.

1. Neuropsychiatric symptoms in Parkinson's disease;Aarsland;Mov. Disord.,2009

2. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability;Anderson;J. Affect. Disord.,2000

3. The 5-HT(2A) receptor antagonist M100907 produces antiparkinsonian effects and decreases striatal glutamate;Ansah;Front. Syst. Neurosci.,2011

4. Immunohistochemical evidence that central serotonin neurons produce dopamine from exogenous L-DOPA in the rat, with reference to the involvement of aromatic L-amino acid decarboxylase;Arai;Brain Res.,1994

5. L-DOPA is converted to dopamine in serotonergic fibers of the striatum of the rat: a double-labeling immunofluorescence study;Arai;Neurosci. Lett.,1995

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Variability in Levodopa Absorption and Clinical Implications for the Management of Parkinson’s Disease;Journal of Parkinson's Disease;2024-08-31

2. Interactions of antidepressants with concomitant medications—safety of complex therapies in multimorbidities;Pharmacological Reports;2024-07-16

3. Striatal serotonin transporter gain-of-function in L-DOPA-treated, hemi-parkinsonian rats;Brain Research;2023-07

4. The Pharmacological Treatment of Chronic Pain: From Guidelines to Daily Clinical Practice;Pharmaceutics;2023-04-06

5. Behavioral and neurochemical interactions of the tricyclic antidepressant drug desipramine with L-DOPA in 6-OHDA-lesioned rats. Implications for motor and psychiatric functions in Parkinson’s disease;Psychopharmacology;2022-09-30